Skutecznosc roznych metod leczenia przewleklej zapalnej choroby jelit u psow

• Autorzy: Rychlik A , Nieradka R. , Depta A. , Paluszewski A. , Sarti K.

Warianty tytułu

EN

Efficacy of different treatment methods in dogs' inflammatory bowel disease

• Języki publikacji: PL

Abstrakty

EN

The aim of study was to determine the effectiveness of different treatments of IBD in dogs, with special attention to treatment solely with mesalazine and its combination with intestinal diet in comparison to combined treatment with (amoxycilin, metoclopramide, famotidine) and intestinal diet alone. The research was carried out on 22 dogs of different sex divided in 4 groups. All dogs showed characteristic symptoms of small intestinal disease. In all groups clinical, hematological, biochemical, urine, endoscopic and histopatological examinations were carried out twice (before and after treatment). The most effective treatment of dogs’ IBD was the application of mesalazine in combination with an intestinal diet. Pharmacological treatment supported with intestinal diet improved its effectiveness and excluded disease recidivism. Panendoscopic examination was demonstrated to be a useful method of examination in IBD diagnosis in dogs showing vomiting and small intestinal diarrhea. The collection of tissues with intestinal biopsy and histopathological analysis of samples enabled the credible diagnosis and treatment of dog IBD.

Słowa kluczowe

PL

psy; choroby zwierzat; przewlekle zapalenie jelit; leczenie; metody; mesalazyna; leczenie dietetyczne; dieta lecznicza typu intestinal; antybiotyki; skutecznosc; diagnostyka; endoskopia

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2008
• Tom: 64
• Numer: 06
• Opis fizyczny: s.796-799,tab.,bibliogr.

Twórcy

autor

Rychlik A

• Uniwersytet Warminsko-Mazurski w Olsztynie, ul.Oczapowskiego 14, 10-957 Olsztyn

autor

Nieradka R.

autor

Depta A.

autor

Paluszewski A.

autor

Sarti K.

Bibliografia

• 1. Allan R. N.: Metabolic problems in inflammatory bowel disease. Netherlands Journal of Medicine 1998, 53, S9-S12.
• 2. Aumais G., Lefebvre M., Massicotte J., Tremblay C., Kasbo J., Brunet J. S., Cardinal C., Grace M., Spenard J.: Pharmacokinetics and pilot efficacy of a mesalazine rectal gel in distal ulcerative colitis. Drugs R D. 2005, 6, 41-46.
• 3. Cipolla G., Crema F., Sacco S., Moro E., de Ponti F., Frigo G.: Nonsteroidal anti-inflammatory drugs and inflammatory bowel disease: current perspectives. Pharmacol. Res. 2002, 46, 1-6.
• 4. Craven M., Simpson J. W., Ridyard A. E., Chandler M. L.: Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002). J. Small Anim. Pract. 2004, 45, 336-342.
• 5. Eaton K. A., Radin M. J., Krakowka S.: Animal models of bacterial gastritis: the role of host, bacterial species and duration of infection on severity of gastritis. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 1993, 280, 28-37.
• 6. Gaag van der I.: The histological appearance of large intestinal biopsies in dogs with clinical signs of large bowel disease. Can. J. Vet. Res. 1988, 52, 75-82.
• 7. Gisbert J. P., Gonzalez-Lama Y., Mate J.: 5-Aminosalicylates and renal function in inflammatory bowel disease: a systematic review. Inflamm. Bowel Disease 2007, 13, 629-638.
• 8. Guilford W. G.: Nutritional management of gastrointestinal tract diseases of dogs and cats. J. Nutr. 1994, 124, 2663-2669.
• 9. Hanauer S. B.: Natural History of corticosteroid therapy for inflammatory bowel disease. Rev. Gastroenterol. Disord. 2002, 2, 93-94.
• 10. Hayden D. W., van Kruiningen H. J.: Lymphocytic-plasmacytic enteritis in German Shepherd Dogs. J. Am. Anim. Hosp. Assoc. 1982, 18, 89-96.
• 11. Hewicker-Trautwein M.: Przewlekłe zapalne enteropatie psów i kotów. Gastroenterologia Małych Zwierząt. Materiały XIV Kongresu PSLWMZ Wrocław 2006, s. 23-26.
• 12. Hoffmann J. C., Pawlowski N. N., Kuhl A. A., Hohne W., Zeitz M.: Animal models of inflammatory bowel disease: an overview. Pathobiology. J. Immunopathol. Mol. Cellul. Biol. 2003, 70, 121-130.
• 13. Jacobs G., Collins-Kelly L., Lappin M., Tyler D.: Lymphocytic-plasmacytic enteritis in 24 dogs. J. Vet. Int. Med. 1990, 4, 45-53.
• 14. Jergens A. E.: Inflammatory bowel disease. Current perspectives. Vet. Clin. North. Am. Small. Anim. Pract. 1999, 29, 501-521.
• 15. Jergens A. E., Gamet Y., Moore F. M., Niyo Y., Tsao C., Smith B.: Colonic lymphocyte and plasma cell populations in dogs with lymphocytic-plasmacytic colitis. Am. J. Vet. Res. 1999, 60, 515-520.
• 16. Jergens A. E., Schreiner C. A., Frank D. E., Niyo Y., Ahrens F. E., Eckersall P. D., Benson T. J., Eyans R.: A scoring index for disease activity in canine inflammatory bowel disease. J. Vet. Intern. Med. 2003, 17, 291-297.
• 17. Leblitz H., Mayer H.: Histologie von chronisch-idiopatischer Enteropatie bei dem Hund. Pathologie. 2001, 37, 721-726.
• 18. Pierik M., Rutgeerts P., Vlietinck R., Vermeire S.: Pharmacogenetics in inflammatory bowel disease. World J. Gastroenterol. 2006, 12, 3657-3667.
• 19. Ransford R. A. J., Langman M. J. S.: Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002, 51, 536-539.
• 20. Roth L., Leib M. S., Davenport D. J., Monroe W. E.: Comparisons between endoscopic and histologic evaluation of the gastrointestinal tract in dogs and cats: 75 cases (1984-1987). J. Am. Vet. Med. Assoc. 1990, 196, 635-638.
• 21. Rutgers H. C., Batt R. M., Kelly D. F.: Lymphocytic-plasmacytic enteritis associated with bacterial overgrowth in a dog. J. Am. Vet. Med. Assoc. 1988, 192, 1739-1742.
• 22. Strombeck D. R.: Chronic inflammatory bowel disease. D. R. Strombeck. Small Animal Gastroenterology. Stonegate Publishing, California 1997, 240-261.
• 23. Tadic M., Grgurevic I., Scukanec-Spojlar M., Bozic B., Marusic S., Horvatic I., Galesic K.: Acute interstitial nephritis due to mesalazine. Nephrology 2005, 10, 103-105.
• 24. Thomsen O. O.: Budesonide and mesalazine in active Crohn's disease: a comparision of the effects on quality of life. Am. J. Gastroenerol. 2002, 97, 649-653.
• 25. Thomsen O. O., Cortot A., Jewell D.: A comparison of budesonide and mesalamine for active Crohn's disease. N. Engl. J. Med. 1998, 339, 370-374.
• 26. Wiersma H., Escher J. C., Dilger H., Trenk D., Benninga M. A., Van Boxtel C. J., Taminau J.: Pharmacokinetics of masalazine pallets in children with inflammatory bowej disease. Inflamm. Bowel Disease 2004, 10, 626-631.
• 27. Wolf A. M.: Feline lymphocytic-plasmacytic enterocolitis. Seminars. Vet. Med. Surg. 1992, 7, 128-133.